Kepivance anvendes hos patienter, der er udsat for at få svær mucositis, fordi de har blodkræft og får myeloablativ behand - ling (dvs. en behandling, der udsletter knoglemarven) og autolog stamcelletransplantation (dvs. trans - plantation af deres egne bloddannende celler).
Kepivance is used in patients who are likely to develop severe mucositis because they have blood cancer, and are being treated with myeloablative therapy (treatments that destroy the bone marrow) and an autologous stem cell transplant (a transplant of their own blood-producing cells).